Remdesivir Gets FDA Approval, but WHO Says Drug Ineffective for COVID
• By Jeremy LoffredoAs far back as April, U.S. National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci was touting Gilead's antiviral remdesivir as "the standard of care for patients with COVID-19."